[HTML][HTML] Adipose tissue dysfunction and obesity-related male hypogonadism

VA Genchi, E Rossi, C Lauriola, R D'Oria… - International Journal of …, 2022 - mdpi.com
Obesity is a chronic illness associated with several metabolic derangements and
comorbidities (ie, insulin resistance, leptin resistance, diabetes, etc.) and often leads to …

[HTML][HTML] Adipose tissue secretion pattern influences β-cell wellness in the transition from obesity to type 2 diabetes

G Biondi, N Marrano, A Borrelli, M Rella… - International Journal of …, 2022 - mdpi.com
The dysregulation of the β-cell functional mass, which is a reduction in the number of β-cells
and their ability to secure adequate insulin secretion, represents a key mechanistic factor …

A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng

Y Liu, H Zhang, X Dai, R Zhu, B Chen, B Xia, Z Ye… - Phytomedicine, 2021 - Elsevier
Abstract Background Radix Ginseng, one of the well-known medicinal herbs, has been used
in the management of diabetes and its complications for more than 1000 years. Purpose The …

[HTML][HTML] Type 2 diabetes and Alzheimer's disease: the emerging role of cellular lipotoxicity

N Marrano, G Biondi, A Borrelli, M Rella, T Zambetta… - Biomolecules, 2023 - mdpi.com
Type 2 diabetes (T2D) and Alzheimer's diseases (AD) represent major health issues that
have reached alarming levels in the last decades. Although growing evidence demonstrates …

[HTML][HTML] Glucose-induced insulin secretion in isolated human islets: Does it truly reflect β-cell function in vivo?

JC Henquin - Molecular metabolism, 2021 - Elsevier
Background Diabetes always involves variable degrees of β-cell demise and malfunction
leading to insufficient insulin secretion. Besides clinical investigations, many research …

[HTML][HTML] The role of beta cell recovery in type 2 diabetes remission

M Suleiman, L Marselli, M Cnop, DL Eizirik… - International journal of …, 2022 - mdpi.com
Type 2 diabetes (T2D) has been considered a relentlessly worsening disease, due to the
progressive deterioration of the pancreatic beta cell functional mass. Recent evidence …

Glucagon in type 2 diabetes: Friend or foe?

I Caruso, N Marrano, G Biondi… - Diabetes/Metabolism …, 2023 - Wiley Online Library
Hyperglucagonemia is one of the 'ominous' eight factors underlying the pathogenesis of type
2 diabetes (T2D). Glucagon is a peptide hormone involved in maintaining glucose …

[HTML][HTML] Metabolic diseases and Down syndrome: how are they linked together?

M Moreau, S Benhaddou, R Dard, S Tolu, R Hamzé… - Biomedicines, 2021 - mdpi.com
Down syndrome is a genetic disorder caused by the presence of a third copy of
chromosome 21, associated with intellectual disabilities. Down syndrome is associated with …

[HTML][HTML] Irisin and incretin hormones: Similarities, differences, and implications in type 2 diabetes and obesity

N Marrano, G Biondi, A Borrelli, A Cignarelli, S Perrini… - Biomolecules, 2021 - mdpi.com
Incretins are gut hormones that potentiate glucose-stimulated insulin secretion (GSIS) after
meals. Glucagon-like peptide-1 (GLP-1) is the most investigated incretin hormone …

[HTML][HTML] The potential roles of artemisinin and its derivatives in the treatment of type 2 diabetes mellitus

Y Jiang, J Shui, B Zhang, J Chin, R Yue - Frontiers in Pharmacology, 2020 - frontiersin.org
Type 2 diabetes mellitus (T2DM) is a chronic disease that has become a global public health
problem. Studies on T2DM prevention and treatment mostly focus on discovering …